NASH drugs are the next blockbusters and ICPT is at the forefront of the science.
In my opinion, this company gets acquired within the year.
FDA approval means a sharply higher open for ICPT tomorrow.
The FDA’s Gastrointestinal Drugs Advisory Committee votes 17-0 backing approval of Intercept Pharmaceuticals’ (ICPT) obeticholic acid (OCA) for the treatment of primary biliary cirrhosis (PBA), accepting the use of the liver enzyme alkaline phosphatase (ALP) as a surrogate endpoint.
French drug maker, Genfit (GNFTF) should get some sympathy love, and maybe GALT.
If you enjoy the content at iBankCoin, please follow us on Twitter
We are all going to live to 120 if this keeps up. The immunotherapy drugs for cancer are insanely good too.
I’d say it’s already ignited the past two days.
Morgan Stanley downgrade….while everyone else upgraded it. I know this approval wasn’t for NASH but rather PBC, but still looks like some shady manipulation here to shake out the weak hands. Fortunately there is a big event on April 13 -17 which will yield who’s right (MS or ICPT).